Richard Beckman, Chief Medical Officer at Adverum Biotechnologies, Inc. (ADVM), sold 4,272 shares at $1.07 ($5K) on 2022-09-19, disclosed to the SEC on 2022-09-21.
Open-market sale of $5k ADVM by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.